New bowel tumor drug helped cure cancer in 100% of cases
Jemperli (dostarlimab) might be a cancer cure breakthrough from GSK, as it cured 100% of rectal cancer cases in a trial.
Source: bgr.com
Hesham Abdullah News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hesham Abdullah. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hesham Abdullah Today - Breaking & Trending Today
GSK Blood Cancer Drug Nearly Halves Risk Of Death In Late-Stage Trial
Published: Sun 2 Jun 2024, 4:57 PM Last updated: Sun 2 Jun 2024, 4:58 PM GSK's multiple myeloma
Source: menafn.com
FDA Accepts sBLA for Dostarlimab With Chemotherapy to Treat Endometrial Cancer
Dostarlimab plus chemotherapy is the only immuno-oncology-based therapy that showed statistically significant and clinically meaningful survival benefit in the overall patient population.
Source: pharmacytimes.com
US regulator accepts GSK's application to expand treatment of cancer drug
The Food and Drug Administration (FDA) has accepted GSK’s application to expand treatment of its cancer-fighting technology, Jemperli.
Source: cityam.com
Dostarlimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit in Endometrial Cancer
In the RUBY phase 3 trial, dostarlimab (Jemperli; GSK) with niraparib (Zejula; GSK) had significant progression free survival compared to the standard of care.
Source: pharmacytimes.com